News|Articles|September 2, 2003

Pharmaceutical Technology

  • Pharmaceutical Technology-09-02-2003
  • Volume 27
  • Issue 9

Counterfeiting, Compliance, and Controls

Author(s)Jill Wechsler

FDA and manufacturers seek to curb drug counterfeiting while legislators consider liberalizing drug importing policies to cut pharmaceutical costs.
External Link - article-70112.pdf

Articles in this issue

about 22 years ago

September 2003

about 22 years ago

In the Spotlight September 2003

about 22 years ago

September 2003

about 22 years ago

The Fabrication And Evaluation of the Formulation Variables of a Controlled-Porosity Osmotic Drug Delivery System with Diltiazem Hydrochloride

about 22 years ago

Disposable Filtration Lightens Cleaning and Validation Load

about 22 years ago

CROs Hoping for Research Burst in Second Half of 2003

about 22 years ago

Positron Emission Particle Tracking Studies of a Wurster Process for Coating Applications

about 22 years ago

Improved Blister Packaging Benefits Consumers, Caregivers, and Drug Makers

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us